microRNA (miRNA) Global Market Report 2022: Increasing Application in Cancer Diagnostics as Biomarkers to Drive Growth

News provided by

Aug 30, 2022, 06:45 ET

DUBLIN, Aug. 30, 2022 /PRNewswire/ -- The "microRNA (miRNA) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global microRNA (miRNA) Market to Reach $485.3 Million by 2026
Key drivers propelling growth in the global microRNA market include greater awareness, increasing emphasis on R&D activities, growth of advanced and well-organized technology, rising government initiatives globally, escalating government investments in healthcare, along with advances in genomic technologies and molecular biology.

The growth of microRNA in oncology can be attributed to the growing burden of cancer as well as other cardiovascular diseases, broader therapeutic applications, lowering the cost of sequencing, and greater acceptance of the technology. Rising microRNA adoption in emerging countries such as India, China, among others will offer new growth opportunities.

The growing use of microRNA biomarkers is augmenting growth in the market. Such biomarkers play a particularly important role in data-driven approaches, genome-wide population-based studies because they show high reproducibility and robustness in comparison to conventional procedures. Furthermore, the growing relevance of liquid biopsies is further driving its popularity in the discovery and development of biomarkers. However, intensified demand for highly skilled personnel and challenges regarding in-house development are major hurdles to growth in the global market.

Amid the COVID-19 crisis, the global market for microRNA (miRNA) estimated at US$282.6 Million in the year 2022, is projected to reach a revised size of US$485.3 Million by 2026, growing at a CAGR of 13.8% over the analysis period.

The U.S. Market is Estimated at $120.5 Million in 2022, While China is Forecast to Reach $50.7 Million by 2026
The microRNA (miRNA) market in the U.S. is estimated at US$120.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$50.7 Million by the year 2026 trailing a CAGR of 17.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 13% respectively over the analysis period.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIE

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Increasing Incidence of Infectious Diseases and Chronic Conditions to Help miRNA Market Gallop Ahead
Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Increasing Application in Cancer Diagnostics as Biomarkers to Drive Market Growth
The Future of miRNA-based Cancer Biomarkers
Consistent Increase in Risks and Threats from Infections Drive Healthy Market Growth
MicroRNA Biomarkers Hold Promise for Diagnosis of Infectious Diseases
Focus on Development of miRNA-based Therapeutics Bodes Well for Market Growth
Increasing Investments in miRNA to Bolster Market Growth
Diagnostics and Therapeutics Investments
Standard Methods Utilized to measure miRNA Biomarkers
Advancements in Detection Methodologies Focus on Enhancing Sensitivity and Selectivity of miRNA Detection
Increasing Demand for Liquid Biopsies to Drive the MicroRNA Market
miRNA by Type of Gastrointestinal Cancers
Circulating miRNAs as Cancer Detectors
Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for the Market
Growing Global Healthcare Spending and Supportive Government Initiatives Boost Market Prospects
miRNA and Next Generation Sequencing